Global Benzodiazepine Drugs Market Analysis/Research Report 2022 Dublin, June 06, 2022 (GLOBE NEWSWIRE) -- The "Global Benzodiazepine Drugs Market by Product, Application, Route of Administration, Distribution Channel, and Region - Size, Share, Outlook, and...

Xeris Pharmaceuticals Awarded Phase I-II NIH SBIR Fast Track Grant to Advance a Stable, Non-Aqueous Diazepam, Subcutaneous Injection for Treatment of Acute Repetitive Seizures in Patients with Epilepsy Austin, Texas, Oct. 01, 2015 (GLOBE NEWSWIRE) -- Xeris Pharmaceuticals, Inc. (“Xeris”), an Austin-based, emerging biopharmaceutical company developing patient-friendly injectable treatments, was...